my cart
  • log-in
  • applications / products

    Applications

    • Drug Discovery & Development
    • Cell Banks for Bioassays
    • Potency & QC Lot Release
    • Detect Neutralizing Abs
    • Cytotoxicity Assays
    • Target Engagement
    • Translocation Assays
    • Targeted Protein Degradation
    • Signaling Pathway Reporters
    • Pharmacotrafficking Assays
    • Do-It-Yourself Assays
    • Therapeutic/Disease Area
    • Custom Development Capabilities

    Products

    • Cells & Cell Lines
    • Assay Ready Kits
    • Bioassay Kits
    • eXpress Kits
    • Frozen Cells
    • Membrane Preps
    • Proteins & Kinases
    • Cell Culture Reagents
    • Detection Reagents
    • Biochemical Assays
    • Control Ligands & Inhibitors
  • targets
    • A-Z List of Targets
    • GPCRs
    • Kinases
    • Checkpoint Receptors
    • Ion Channels
    • Cytokines & Interleukins
    • Signaling Pathways
    • Nuclear Proteins
    • Epigenetics Proteins
  • technologies / platforms
    • Enzyme Fragment Complementation
    • Human Primary Cell Screening
    • Competition Binding Platform
  • tools / resources

    Document Resource Library

    • Flyers & Brochure
    • User Manuals & Protocols
    • White Papers & Applications
    • Scientific Posters
    • Presentations

    Webinars

    Knowledge-Based Videos

    Blogs

    Publications & References

    CRO Certification

    Reagent Calculators

    Instrument Compatibility

  • services
  • Contact Us
    • Customer & Technical Support
    • Submit an Order
    • Technical Resources
    • Literature & Email Signup
    • Legal & Policies
    • Locations
    • Distributors
    • Procurement Partners
  • about us
    • Company
    • Contact Us
    • Careers
    • Announcements
    • Events
About Us / Announcements
Contact a Specialist
About Us
  • Careers
  • Announcements
  • Events

News & Press Releases





3/5/2014
Research by Structural Genomics Consortium and DiscoveRx Points to New Multi-Targeting Approaches to Cancer Therapy

Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins

11/20/2013
Leading Drug Discovery Scientists Leverage PathHunter® Arrestin Technology for Discovery of Novel GPCR Drugs

10/22/2013
DiscoveRx Expands into Immunology Market with Launch of New Human Primary Cell-Based T Cell Autoimmune Panel

9/12/2013
DiscoveRx Announces Launch of New Human Primary Cell-Based Panels for Oncology Research

11/7/2012
Discoverx Corporation Acquires BioSeek® - Adds Primary Cell Assays to Portfolio of Drug Discovery Solutions

6/5/2012
DiscoveRx Breaks the Barriers of Conventional Cell-Based Screening With Launch of a Powerful New InCELL Hunterâ„¢ Platform

5/16/2012
DiscoveRx Introduces a High-Throughput Biochemical Screening Platform for Bromodomain Epigenetic "Reader" Proteins

5/1/2012
Comprehensive PathHunter® Assay Portfolio Driving Antibody Therapeutic Discovery Programs

2/3/2012
DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs

11/29/2011
Compugen and DiscoveRx® Form Collaboration to Commercialize Novel Peptide Ligands for GPCR Drug Targets

Displaying results 21-30 (of 45)
 |<  <  1 - 2 - 3 - 4 - 5  >  >| 
+ sitemap © 2020 Eurofins DiscoverX Products. All rights reserved.
  • Contact Us
  • Legal & Privacy
  • Cookie Notice